Today’s pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry’s major underlying drivers — higher rates of cancer and chronic disease — are still at play and not expected to dissipate. The US reigns supreme…
The global oil market is facing a sharp downturn as a wave of recession fears, aggressive trade policies and…
Private specialty chemicals company Maverick Metals has raised US$19 million in a seed funding round led by Olive Tree…
Highlights Attributable resource to CEL 6.9 Moz AuEq2 across El Guayabo (100%) and Colorado V (50%). Significant upside remains:…
HIGHLIGHTS: 8.85m grading 25.0 g/t gold and 768 g/t silver 8.55m grading 5.52 g/t gold and 121 g/t silver…
(TheNewswire) Silver Crown Royalties Inc. ( Cboe: SCRI, OTCQX: SLCRF, BF: QS0 ) ( ‘Silver Crown’ ‘SCRi’ the ‘Corporation’…
Greenvale Energy (GRV:AU) has announced Alpha Test Program 6 Continues to Deliver Improved Results Download the PDF here. This…
Rare earth elements (REEs) are crucial for technologies like smartphone cameras and defense systems. A select few from the…